Sign in
Enrolling by invitationNo phase

Studies how genes, diet and gut microbes relate to digestive conditions

Studies how diet, genes and gut bacteria affect digestive conditions in adults.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Enabling Microbiomics- Driven Personalized Nutrition
Status
Enrolling by invitation
People taking part
4,001 people, planned
Started
28 Mar 2025
Expected to end
Apr 2028
Type of study
Observational
Record updated
12 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with gut conditions such as IBD, IBS, Crohn's disease, celiac disease, diarrhea or constipation. It also takes healthy adults without gut disease as controls.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Gastrointestinal patients in these groups: Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Crohn's Disease, Celiac Disease, Diarrhea, Constipation. Healthy controls have no gastrointestinal disease or symptoms at the time of sampling.
Biomarker or test result
Genomic sequencing results may be available, but are not required.

Main reasons for not taking part

  • Cognitive impairment
  • Active use of antibiotics at the time of stool collection
  • No smartphone with internet access
  • Cannot give written, informed consent

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age greater than or equal to 18 years
  • Gastrointestinal patients with or without genomic sequencing results available for the following cohorts:; Inflammatory Bowel Disease (IBD); Irritable Bowel Syndrome (IBS); Crohn's Disease; Celiac Disease; Diarrhea; Constipation
  • Healthy age and sex matched controls with or without genomic sequencing results available; o Control is defined as patients without gastrointestinal disease or no symptoms at time of sampling
  • Able to provide written, informed consent
  • Participant has a smartphone device with access to internet connection

Who cannot take part

  • Patients with cognitive impairment
  • Active use of antibiotics at the time of stool collection

Where in United States

  • Mayo ClinicRochester, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The goal of this observational research study is to determine how diet contributes to various gastrointestinal related conditions.

Read full original descriptionShow less

The main question investigators aim to answer is:

Are host genetics, diet, and microbiome all important determinants of GI disorders, and how their relative contribution varies among individuals and populations.

The group in the trial

  • GI Disorders

    Inflammatory Bowel Disease, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Diarrhea, Constipation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Enabling Microbiomics- Driven Personalized Nutrition (EMPOWER)
Plain-language title
Studies how genes, diet and gut microbes relate to digestive conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
12 June 2026